Loading clinical trials...
Loading clinical trials...
Phase 2 Study of ADI PEG 20 in Non-Hodgkin's Lymphoma Subjects Who Have Failed Prior Systemic Therapy
Conditions
Interventions
ADI-PEG 20
Locations
5
Taiwan
Chang Gung Medical Foundation-Kaohsiung
Kaohsiung City, Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
CMUH
Taichung, Taiwan
National Cheng Kung University Hospital(NCKUH)
Tainan, Taiwan
CGMH-LK
Taoyuan District, Taiwan
Start Date
December 6, 2013
Primary Completion Date
August 31, 2016
Completion Date
December 15, 2017
Last Updated
September 18, 2018
NCT06667687
NCT05623982
NCT03314974
NCT04586478
NCT05054257
NCT01746849
Lead Sponsor
Polaris Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions